MAP2K1 and melanoma: Therefore, we analyzed the cytotoxicity, using freshly purified resting allogenic NK cells as effectors and AR-positive WM266-4 (Fig. 1C), AMM16 (Fig. 1D), MEL-CAL (Fig. 1E) and LCM-Mel (Fig. 1F) melanoma cells as targets.